Palatin Technologies Inc (PTN)

Healthcare | Biotechnology
Latest reporting period: 2025-09-30

Latest Quarter

2025-09-30

Revenue

$8.8M

Net Income

$4.7M

Operating Margin

52.7%

Free Cash Flow

-$21.3M

Debt / Assets

246.2%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Palatin Technologies Inc (PTN).
Income Statement (Quarterly) 2025-09-30 2025-03-31 2024-12-31 2024-09-30
Revenue 8,847,550 0 0 0
Cost of Revenue 0 0 0 0
Gross Profit 8,847,550 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 0 1,474,019 1,681,844 2,020,931
Operating Expenses 4,186,497 5,229,177 2,611,323 7,764,685
Operating Income 4,661,053 -4,813,177 -2,611,323 -7,764,685
Interest Expense 2,002 -1,795 3,803 5,940
Income Before Tax 4,677,534 -4,811,420 -2,442,482 -7,823,649
Income Tax Expense 0 0 0 0
Net Income 4,677,534 -4,811,420 -2,442,482 -7,823,649
Per Share
EPS 4.81 -0.18 -0.12 -0.39
EPS Diluted 0.00 0.00 0.00 0.00